Lancet 397:17361748 Lau DCW, Erichsen L, Francisco AM, Satylganova A et al (2022) Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial
New data is regularly published, finding new or magnified benefits of GLP-1s
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub
Its essential to remember that these results are based on clinical trials, and individual results may vary due to the numerous factors influencing weight loss outcomes with semaglutide
Collagen production is ramping up, though structural changes in the skin matrix take longer to become obvious